ISSN: 1746-0751

Journal Home

Journal Guideline

Regenerative Medicine Q2 Unclaimed

Taylor and Francis Ltd. United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Regenerative Medicine is a journal indexed in SJR in Biomedical Engineering and Embryology with an H index of 74. It has an SJR impact factor of 0,517 and it has a best quartile of Q2. It has an SJR impact factor of 0,517.

Regenerative Medicine focuses its scope in these topics and keywords: cells, human, stem, tissueengineered, studies, stromal, research, reach, pulp, tracheobronchial, ...

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Embryology (Q2) Biomedical Engineering (Q3)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,517

SJR Impact factor

74

H Index

68

Total Docs (Last Year)

263

Total Docs (3 years)

3158

Total Refs

584

Total Cites (3 years)

248

Citable Docs (3 years)

1.77

Cites/Doc (2 years)

46.44

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Advanced Biosystems Q2
IEEE Journal of Translational Engineering in Health and Medicine Q2
BioChip Journal Q2
Tissue Engineering - Part A Q2
Tissue Engineering - Part A. Q2

Compare this journals

Aims and Scope

Best articles by citations

Hypocellularity and absence of compaction as criteria for embryonic death

Tendon and ligament engineering: from cell biology toin vivoapplication

Update on therapeutic vascularization strategies

3D scaffolds for bone marrow stem cell support in bone repair

Applications of gene therapy and adult stem cells in bone bioengineering

Engineering stem cells for therapy

Bone marrow-derived stem cells in neurological diseases: stones or masons?

What is the role of the vasculature in the neural stem cell niche?

Research Highlights

Controlled mechanotransduction in therapeutic MSCs: can remotely controlled magnetic nanoparticles regenerate bones?

Definitive endoderm from embryonic stem cells

California dreaming? A new start for regenerative medicine in the Golden State

SHOW MORE ARTICLES

Conversion of embryonic stem cells into pancreatic beta-cell surrogates guided by ontogeny

Engineered mesenchymal stem cells for cartilage repair

Reimbursement and adoption of advanced therapies: the 5-C framework

The time has come to engineer tissues and not just tissue engineer

Reversal of Type 1 diabetes mellitus without exogenous cells

Does the regeneration of hippocampal neurons offer hope for the treatment of cognitive deficits?

Delivery of mesenchymal stem cells in biomimetic engineered scaffolds promotes healing of diabetic ulcers

Letter to the editor: Therapeutic misconception and the role of the Research Ethics Committee

Portrayal of umbilical cord blood research in the North American popular press: promise or hype?

The past, present and future of ligament regenerative engineering

It's endoderm...definitively!

Latest developments in the field of stem cell research and regenerative medicine compiled from publicly available information and press releases from non-academic institutions from May 1, 2014 until June 30, 2014